期刊文献+

2016年—2021年南阳市6787株结核分枝杆菌耐药特征及其分析 被引量:7

Drug resistance and analysis of 6787 Mycobacterium tuberculosis strains in Nanyang City during 2016-2021
原文传递
导出
摘要 目的 分析南阳市结核分枝杆菌对一线和部分二线抗结核药物的耐药情况,为本地区结核病的诊断、治疗以及预防工作提供参考和科学依据。方法 共选择分析2016年—2021年于南阳六院就诊的肺结核患者培养阳性菌株,采用比例法进行菌种分型以及药物敏感性试验,监测对链霉素、异烟肼、利福平、乙胺丁醇、氧氟沙星、阿米卡星等6种抗结核药物的耐药性。结果 共培养结核分枝杆菌6 787例,非结核分枝杆菌(NTM)604例,总耐药率为18.9%,广泛耐药率为1.2%,初始耐药率为17.2%,获得性耐药率为41.7%。耐多药率为7.2%,初治耐多药率为4.9%,获得性耐多药率为39.4%,6种抗结核药物的耐药率由高到低分别为链霉素(11.9%)、异烟肼(8.9%)、利福平(8.6%)、氧氟沙星(6.1%)、乙胺丁醇(5.8%)、卡那霉素(1.3%)。结论 南阳六院分离出的结核分枝杆菌耐多药率和二线药物耐药率均偏高,尤其是复治患者,南阳市区及各辖县应加强结核病患者登记治疗管理工作,合理使用二线药物。 Objective To retrospectively analyze the resistance ofMycobacterium tuberculosisto first-line and some second-line anti-tuberculosis drugs in Nanyang City,Henan Province,so as to provide reference and scientific basis for the diagnosis,treatment and prevention of tuberculosis in this region.Methods Positive strains cultured from tuberculosis patients of Nanyang Sixth People.s Hospital between 2016 and 2021 were selected as test samples.The identification test and drug susceptibility test of those strains were carried out based on the scaling method,which aimed to investigate their resistance to six anti-tuberculosis drugs including streptomycin(S),isoniazid(H),rifampicin(R),ethambutol(E),ofloxacin(O) and amikacin(K).Results A total of 6 787 strains ofMycobacterium tuberculosisand 604 strains of nontuberculosis mycobacteria were cultured.The total drug resistance rate was 18.9%,the extensively drug resistance rate was 1.2%,the initial drug resistance rate was17.2%,and the acquired drug resistance rate was 41.7%.The multi-drug resistance rate was 7.2%,the initial multi-drug resistance rate was 4.9%,and the acquired multi-drug resistance rate was 39.4%.The drug resistance rate of the six anti-tuberculosis drugs ranged from high to low:streptomycin(S)(11.9%),isoniazid(H)(8.9%),rifampicin(R)(8.6%),ofloxacin(O)(6.1%),ethambutanol(E)(5.8%),kanamycin(K)(1.3%).Conclusion The multi-drug resistance rate and second-line drugs resistance rate ofMycobacterium tuberculosisare relatively high among tuberculosis patients of Nanyang Sixth People.s Hospital,particularly among those who had retreatment.Therefore,it is necessary to strengthen the treatment and management of tuberculosis patients and the clinical rational use of second-line drugs in Nanyang City.
作者 肖亚利 张璐 XIAO Ya-li;ZHANG Lu(Nanyang Sixth People􀆳s Hospital,Nanyang,Henan 473000,China;不详)
出处 《中国卫生检验杂志》 CAS 2022年第15期1894-1897,共4页 Chinese Journal of Health Laboratory Technology
关键词 结核分枝杆菌 耐药 分析 Mycobacterium tuberculosis Drug resistance Analysis
  • 相关文献

参考文献13

二级参考文献100

  • 1张国龙,杜长梅,苍泽卓也,池田雄史,王伟,石瑞如.中日合作对河南省结核菌二线药物耐药监测研究[J].医药论坛杂志,2005,26(19):14-16. 被引量:15
  • 2梅建,薛桢,沈鑫,沈国妙,桂晓红,沈梅,高谦.原发性耐药是耐药结核病产生的重要原因[J].中华结核和呼吸杂志,2006,29(2):75-78. 被引量:103
  • 3杜长梅,王国斌,徐吉英,王国杰,胡惠义,甄新安,李爱华,孙占强,闫国蕊.河南省第二轮结核病耐药监测及耐药趋势研究[J].中国防痨杂志,2006,28(2):95-100. 被引量:26
  • 4中华人民共和国卫生部.全国结核病耐药性基线调查报告(2007-2008年).北京:人民卫生出版社,2010:4.
  • 5中华人民共和国卫生部.WS288-2008肺结核诊断标准.北京:人民卫生出版社,2008.
  • 6中华人民共和国国家统计局.北京:中国统计年鉴2010.[M].中国统计出版社,2010.
  • 7Espinal MA,Laszlo A,Simonsen L,et al.Global trends in resistance to antituberculosis drugs.World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance[J].N Engl J Med,2001,344 (17):1294 -1303
  • 8Nachega JB,Chaisson RE.Tuberculosis drug resistance:a global threat[J].Clin Infect Dis,2003,36(Suppl 1):S24-30
  • 9Iseman MD.MDR-TB and the developing world-a problem no longer to be ignored:the WHO announces 'DOTS Plus' strategy[J].Int J Tuberc Lung Dis,1998,2(11):867
  • 10WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance.Anti-tuberculosis drug resistance in the world.Third report[J].WHO/HTM/TB/2004.343.Geneva:WHO,2004

共引文献3068

同被引文献83

引证文献7

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部